Therapeutic modulation of low-density lipoprotein size.
Small, dense LDL particles have been linked to atherosclerosis, often in a cluster of risk factors and affecting approximately 20% of adults. Over the past year, studies confirmed that small dense LDL is an autosomal dominant trait, influenced mainly by hypertriglyceridaemia and obesity, insulin resistance and diabetes mellitus and some incompletely investigated genetic loci. Compositional and functional differences have been observed in small LDL. Evidence is emerging that lifestyle as well as pharmacological intervention can modulate LDL size, but there is no proof yet that this is of clinical benefit.
Marais
A D
AD
Lipid Laboratory, Cape Heart Centre and MRC Cape Heart Group, University of Cape Town Health Sciences Faculty, Anzio Road, Observatory 7925, South Africa. dmarais@uctgsh1.uct.ac.za
D001161:Arteriosclerosis / Q000378:metabolism* / Q000517:prevention & control; D003920:Diabetes Mellitus / Q000378:metabolism; D006801:Humans; D015228:Hypertriglyceridemia / Q000378:metabolism; D007333:Insulin Resistance; D008077:Lipoproteins, LDL / Q000737:chemistry* / Q000235:genetics / Q000378:metabolism*; D009765:Obesity / Q000378:metabolism; D012306:Risk; D012307:Risk Factors
D008077:Lipoproteins, LDL